[3H]dihydrorotenone binding to NADH: Ubiquinone reductase (complex I) of the electron transport chain: An autoradiographic study

Journal of Neuroscience

Volumn 16, Issue 12, 1996, Pages 3807-3816

  Higgins Jr , Donald S ^a,c   Greenamyre, J Timothy ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

amobarbitol; autoradiography; complex I; electron transport chain; mitochondria; MPP+; rotenone; 3H dihydrorotenone

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); ROTENONE; 1 METHYL 4 PHENYLPYRIDINIUM; 1',2'-DIHYDROROTENONE; ADENINE NUCLEOTIDE; DIHYDROROTENONE; DRUG DERIVATIVE; INSECTICIDE; N METHYLASPARTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTORADIOGRAPHY; DATA ANALYSIS; ELECTRON TRANSPORT; ENERGY METABOLISM; LIGAND BINDING; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; RESPIRATORY CHAIN; ANIMAL; BRAIN; CHEMISTRY; DRUG EFFECT; ENTORHINAL CORTEX; ENZYMOLOGY; METABOLISM; MITOCHONDRION; PHYSIOLOGY; SENSITIVITY AND SPECIFICITY; SPRAGUE DAWLEY RAT;

1-METHYL-4-PHENYLPYRIDINIUM; ADENINE NUCLEOTIDES; ANIMALS; AUTORADIOGRAPHY; BRAIN; ELECTRON TRANSPORT; ENTORHINAL CORTEX; INSECTICIDES; MALE; MITOCHONDRIA; N-METHYLASPARTATE; NAD; NAD(P)H DEHYDROGENASE (QUINONE); RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SENSITIVITY AND SPECIFICITY; TRITIUM;

EID: 0029665268     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-12-03807.1996     Document Type: Article

References (47)

1. Andreani A, Rambaldi M, Locatelli A, Leoni A, Ghelli A, Degli Espositi M (1994) Thienylvinylindoles as inhibitors of mitochondrial NADH dehydrogenase. Pharm Acta Helv 69:15-20.
2. Belogrudov G, Hatefi Y (1994) Catalytic sector of complex I (NADH: ubiquinone oxidoreductase): subunit stoichiometry and substrate induced conformation changes. Biochemistry 33:4571-4576.
3. Benecke R, Strumper P, Weiss H (1992) Electron transfer complex I defect in idiopathic dystonia. Ann Neurol 32:683-686.
4. Bindoff LA, Birch-Martin M, Cartlidge NEF, Parker WD, Turnbull DM (1989) Mitochondrial function in Parkinson's disease. Lancet 1:49.
5. Blandini F, Greenamyre JT (1995) Effects of subthalamic nucleus lesions on mitochondrial enzyme activity in the rat basal ganglia. Brain Res 669:59-66.
6. Blandini F, Porter RHP, Greenamyre JT (1995) Autoradiographic study of mitochondrial complex I and glutamate receptors in the basal ganglia of rats after unilateral subthalamic lesion. Neurosci Lett 186:99-102.
7. Capaldi RA (1990) Structure and function of cytochrome c oxidase. Annu Rev Biochem 59:569-596.
8. 0-type ATPases. Trends Biochem Sci 19:284-289.
9. Caughey WS, Wallace WJ, Volpe JA, Yoshikawa S (1976) Cytochrome c oxidase. In: The enzymes (Boyer PD, ed), pp 299-345. New York: Academic.
10. Clay VJ, Ragan CI (1988) Evidence of the existence of tissue specific isoenzymes of mitochondrial NADH dehydrogenase. Biochem Biophys Res Commun 157:1423-1428.
11. Cooper JM, Clark JB (1994) The structural organization of the mitochondrial respiratory chain. In: Mitochondrial disorders in neurology (Schapira AHV, DiMauro S, eds), pp 1-30. New York: Butterworth-Heinemann.
12. Davis GC, Williams AC, Markey SP, Ebert MH, Caine ED, Reichert CM, Kopin IJ (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1:249-254.
13. deJong AMPh, Kotylar AB, Albracht SPJ (1994) Energy-induced structural changes in NADH:Q oxidoreductase of the mitochondrial respiratory chain. Biochim Biophys Acta 1186:163-171.
14. 3H]dihydrorotenone. FEBS Lett 219:108-113.
15. Erecinska M, Silver IA (1989) ATP and brain function. J Cereb Blood Flow Metab 9:2-19.
16. Ernster L, Jailing O, Low H, Lindberg O (1955) Alternate pathways of mitochondrial DPNH oxidation studies with amytal. Exp Cell Res (Suppl) 3:124-132.
17. Ernster L, Dallner G, Azzone OF (1963) Differential effects of rotenone and amytal on mitochondrial electron and energy transfer. J Biol Chem 238:1124-1131.
18. Filser M, Werner S (1988) Pethidine analogues, a novel class of potent inhibitors of mitochondrial NADH:ubiquinone reductase. Biochem Pharmacol 37:2551-2558.
19. Greenamyre JT, Higgins DS, Eller RV (1992) Quantitative autoradiography of dihydrorotenone binding to complex I of the electron transport chain. J Neurochem 59:746-749.
20. Gutman M, Singer TP, Casida JE (1970) Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase: XVII. Reaction sites of piericidin A and rotenone. J Biol Chem 245:1992-1997.
21. Hatefi Y (1973) Oxidation of reduced triphosphopyridine nucleotide by submitochondrial particles from beef heart. Biochem Biophys Res Commun 50:978-984.
22. Hatefi Y (1985) The mitochondrial electron transport and oxidative phosphorylation system. Annu Rev Biochem 54:1015-1069.
23. Hatefi Y, Hanstein WG (1973) Interactions of reduced and oxidized triphosphopyridine nucleotides with the electron-transport system of bovine heart mitochondria. Biochemistry 12:3515-3522.
24. Hevner RF, Liu S, Wong-Riley MTT (1995) A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitometric and biochemical studies. Neuroscience 65:313-342.
25. Hofhaus G, Weiss H, Leonard K (1991) Electron microscopic analysis of the peripheral and membrane parts of mitochondrial NADH dehydrogenase (complex I). J Mol Biol 221:1027-1043.
26. +) the neurotoxic metabolite of MPTP. Biochem Biophys Res Commun 148:684-693.
27. Horgan DJ, Singer TP, Casida JE (1968) Studies on the respiratory chain-linked reduced nicotinamide adenine dinucleotide dehydrogenase: XIII. Binding sites of rotenone, piericidin A and amytal in the respiratory chain. J Biol Chem 243:834-843.
28. Levisohn LF, Isacson O (1991) Excitotoxic lesions of the rat entorhinal cortex. Effects of selective neuronal damage on acquisition and retention of a non-spatial reference memory task. Brain Res 564:230-244.
29. Marshall JF, Critchfield JW, Kozlowski MR (1981) Altered succinate dehydrogenase activity of basal ganglia following damage to mesotelencephalic dopaminergic projection. Brain Res 212:367-377.
30. Munson PJ, Rodbard D (1980) Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 107:220-239.
31. Nicklas WJ, Vyas I, Heikkila RE (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-i,2,3,6-tetrahydropyridine. Life Sci 36:2503-2508.
32. Pandykula HA (1952) The localization of succinic dehydrogenase in tissue sections of the rat. Am J Anat 91:107-145.
33. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. Sydney: Academic.
34. Pilkington SJ, Arizmendi JM, Fearnley IM, Runswick MJ, Skehel JM, Walker JE (1993) Structural organization of complex I from bovine mitochondria. Biochem Soc Trans 21:26-31.
35. Porter RHP, Greene JO, Higgins DS, Greenamyre JT (1994) Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion. J Neurosci 14:7192-7199.
36. Ramsay RR, McKeown KA, Johnson EA, Booth RG, Singer TP (1987) Inhibition of NADH oxidation by pyridine derivatives. Biochem Biophys Res Commun 146:53-60.
37. +) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. J Neurochem 56:1184-1190.
38. Rieske JS (1976) Composition, structure and function of complex III of the respiratory chain. Biochim Biophys Acta 456:195-247.
39. Schapira AHV, Cooper JM, Dexter D, Clark JB, Jenner P, Marsden CD (1990a) Mitochondrial complex I deficiency in Parkinson's disease. J Neurochem 54:823-827.
40. Schapira AHV, Mann VM, Cooper JM, Dexter D, Daniel SE, Jenner P, Clark JB, Marsden CD (1990b) Anatomic and disease specificity of NADHCoQ1 reductase (complex I) deficiency in Parkinson's disease. J Neurochem 55:2142-2145.
41. Shoffner JM, Watts RL, Juncos JL, Torrini A, Wallace DC (1991) Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 30:332-339.
42. Singer TP, Ramsay RR (1994) The reaction sites of rotenone and ubiquinone with mitochondrial NADH dehydrogenase. Biochim Biophys Acta 1187:198-202.
43. Smith PR, Cooper JM, Govan GO, Harding AE, Schapira AHV (1994) Platelet mitochondrial function in Leber's hereditary optic neuropathy. J Neurol Sci 122:80-83,
44. Trijbels JMF, Scholte HR, Ruitenbeek W, Sengers RCA, Janssen AJM, Busch HFM (1993) Problems with the biochemical diagnosis in mitochondrial (encephalo-) myopathies. Eur J Pediatr 152:178-184.
45. Ueno H, Miyoshi H, Ebisui K, Iwamura H (1994) Comparison of the inhibitory action of natural rotenone and its stereoisomers with various NADH-ubiquinone reductases. Eur J Biochem 225:411-417.
46. Wong-Riley M (1979) Changes in the visual system of the monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res 171:11-28.
47. Wong-Riley MTT (1989) Cytochrome oxidase: an endogenous metabolic marker for neuronal activity. Trends Neurosci 12:94-101.